Spring is just around the corner, and The Aesthetic Society is already experiencing renewed energy and new growth. I wanted to answer some questions about what’s next.
In this month’s update, Dr. Tracy Pfeifer highlights all our webinars, like Master Class and AlliedPro Forum, all the travels from New York to Florida, recapping the Facial and Rhinoplasty Symposium and the upcoming The MEET 2026 in Boston!
For this post hoc analysis, the authors extracted and analyzed data from the BLESS III study to determine whether there were variances in the effectiveness and safety of letibotulinumtoxinA for treating vertical glabellar lines between the broader female study population and a group of female participants aged 35 to 50.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
Do you have an idea for a study but don’t where to start or how to finance it? The Aesthetic Foundation has awarded over $3 Million dollars to aesthetic surgery research since it was founded in 1993.